Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Prostate Cancer Non-Metastatic × darolutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Prostate Cancer Non-Metastatic 1 Prostate Cancer Metastatic 1 Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Genital Diseases, Male 1 Biochemically Recurrent Prostate Cancer 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02200614 2022-06-28

ARAMIS

Bayer

Phase 3 Completed

1,509 enrolled 13 charts 1 FDA

Prostate Cancer Non-Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡